Statin decreases endothelial microparticle release from human coronary artery endothelial cells: Implication for the Rho-kinase pathway

Biochemical and Biophysical Research Communications

Volumn 320, Issue 1, 2004, Pages 34-38

  Tramontano, Anthony F ^a,b   O'Leary, Jeanne ^a   Black, Aislinn D ^a   Muniyappa, Ranganath ^a   Cutaia, Michael V ^a,b   El Sherif, Nabil ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Endothelial microparticle; HMG CoA reductase inhibitor; Rho GTPase

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RHO KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROSCLEROSIS; CELL ACTIVATION; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MEMBRANE VESICLE; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

ANTIGENS, CD; ARTERIES; CELLS, CULTURED; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; FATTY ACIDS, MONOUNSATURATED; HUMANS; INDOLES; INTEGRIN ALPHAV; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE GLYCOPROTEINS; PARTICLE SIZE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 2942682635     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.05.127     Document Type: Article

References (22)

1. Creager M.A., Luscher T.F., Cosentino F., Beckman J.A. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation. 108:2003;1527-1532
2. Bernal-Mizrachi L., Jy W., Jimenez J.J., Pastor J., Mauro L.M., Horstman L.L., de Marchena E., Ahn Y.S. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am. Heart J. 145:2003;962-970
3. Mallat Z., Benamer H., Hugel B., Benessiano J., Steg P.G., Freyssinet J.M., Tedgui A. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation. 101:2000;841-843
4. Jimenez J.J., Jy W., Mauro L.M., Soderland C., Horstman L.L., Ahn Y.S. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb. Res. 109:2003;175-180
5. Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., Langendorfer A., Stein E.A., Kruyer W., Gotto A.M. Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air force/Texas coronary atherosclerosis prevention study. JAMA. 279:1998;1615-1622
6. McFarlane S.I., Muniyappa R., Francisco R., Sowers J.R. Pleiotropic effects of statins: lipid reduction and beyond. J. Clin. Endocrinol. Metab. 87:2002;1451-1458
7. Ridley A.J. Rho GTPases and cell migration. J. Cell Sci. 114:2001;2713-2722
8. Takemoto M., Liao J.K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 21:2001;1712-1719
9. Omori H., Nagashima H., Tsurumi Y., Takagi A., Ishizuka N., Hagiwara N., Kawana M., Kasanuki H. Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects. Br. J. Clin. Pharmacol. 54:2002;395-399
10. Ren X.D., Schwartz M.A. Determination of GTP loading on Rho. Methods Enzymol. 325:2000;264-272
11. Horstman L.L., Jy W., Jimenez J.J., Ahn Y.S. Endothelial micoparticles as markers of endothelial dysfunction. Front. Biosci. 9:2004;1118-1135
12. Musial J., Undas A., Gajewski P., Jankowski M., Sydor W., Szczeklik A. Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia. Int. J. Cardiol. 77:2001;247-253
13. Laufs U., Liao J.K. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J. Biol. Chem. 273:1998;24266-24271
14. Teupser D., Bruegel M., Stein O., Stein Y., Thiery J. HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells. Biochem. Biophys. Res. Commun. 289:2001;838-844
15. Topol E.J. Intensive statin therapy - a sea change in cardiovascular prevention. N. Engl. J. Med. 350:2004;1562-1564
16. Rasmussen L.M., Hansen P.R., Nabipour M.T., Olesen P., Kristiansen M.T., Ledet T. Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells. Biochem. J. 360:2001;363-370
17. Fischetti F., Carretta R., Borotto G., Durigutto P., Bulla R., Meroni P.L., Tedesco F. Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation. Clin. Exp. Immunol. 135:2004;186-193
18. Mitani H., Egashira K., Ohashi N., Yoshikawa M., Niwa S., Nonomura K., Nakashima A., Kimura M. Preservation of endothelial function by the HMG-CoA reductase inhibitor fluvastatin through its lipid-lowering independent antioxidant properties in atherosclerotic rabbits. Pharmacology. 68:2003;121-130
19. Omi H., Okayama N., Shimizu M., Fukutomi T., Imaeda K., Okouchi M., Itoh M. Statins inhibit high glucose-mediated neutrophil-endothelial cell adhesion through decreasing surface expression of endothelial adhesion molecules by stimulating production of endothelial nitric oxide. Microvasc. Res. 65:2003;118-124
20. Price D.T., Loscalzo J. Cellular adhesion molecules and atherogenesis. Am. J. Med. 107:1999;85-97
21. Kataoka C., Egashira K., Inoue S., Takemoto M., Ni W., Koyanagi M., Kitamoto S., Usui M., Kaibuchi K., Shimokawa H., Takeshita A. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats. Hypertension. 39:2002;245-250
22. Mallat Z., Gojova A., Sauzeau V., Brun V., Silvestre J.S., Esposito B., Merval R., Groux H., Loirand G., Tedgui A. Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice. Circ. Res. 93:2003;884-888